127 related articles for article (PubMed ID: 8057529)
1. Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in various models of acute renal failure in rats.
Yao K; Kusaka H; Sano J; Sato K; Karasawa A
Jpn J Pharmacol; 1994 Apr; 64(4):281-8. PubMed ID: 8057529
[TBL] [Abstract][Full Text] [Related]
2. Effects of KW-3902, a novel adenosine A1-receptor antagonist, on cephaloridine-induced acute renal failure in rats.
Nagashima K; Kusaka H; Sato K; Karasawa A
Jpn J Pharmacol; 1994 Jan; 64(1):9-17. PubMed ID: 8164396
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats.
Yao K; Kusaka H; Sato K; Karasawa A
Jpn J Pharmacol; 1994 Jun; 65(2):167-70. PubMed ID: 7967229
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats.
Nagashima K; Kusaka H; Karasawa A
Jpn J Pharmacol; 1995 Apr; 67(4):349-57. PubMed ID: 7650867
[TBL] [Abstract][Full Text] [Related]
5. Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a novel adenosine A1 receptor antagonist, in conscious dogs.
Kobayashi T; Mizumoto H; Karasawa A
Biol Pharm Bull; 1993 Dec; 16(12):1231-5. PubMed ID: 8130772
[TBL] [Abstract][Full Text] [Related]
6. Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized dogs.
Yamagata T; Kobayashi T; Kusaka H; Karasawa A
Biol Pharm Bull; 1994 Dec; 17(12):1599-603. PubMed ID: 7735202
[TBL] [Abstract][Full Text] [Related]
7. Effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), an adenosine A1-receptor antagonist, on urinary excretions of various electrolytes in rats.
Nagashima K; Karasawa A
Biol Pharm Bull; 1996 Jul; 19(7):940-3. PubMed ID: 8839965
[TBL] [Abstract][Full Text] [Related]
8. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
Mizumoto H; Karasawa A; Kubo K
J Pharmacol Exp Ther; 1993 Jul; 266(1):200-6. PubMed ID: 8331558
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions.
Kusaka H; Karasawa A
Jpn J Pharmacol; 1993 Dec; 63(4):513-9. PubMed ID: 8121084
[TBL] [Abstract][Full Text] [Related]
10. Effect of the selective adenosine A1-receptor antagonist KW-3902 on lipopolysaccharide-induced reductions in urine volume and renal blood flow in anesthetized dogs.
Yao K; Ina Y; Nagashima K; Ohno T; Karasawa A
Jpn J Pharmacol; 2000 Nov; 84(3):310-5. PubMed ID: 11138732
[TBL] [Abstract][Full Text] [Related]
11. Effects of KW-3902, an adenosine A1-receptor antagonist, on ascites volume in puromycin aminonucleoside (PAN)-induced nephrotic rats.
Kusaka H; Nagashima K; Karasawa A
Jpn J Pharmacol; 1995 Jun; 68(2):213-6. PubMed ID: 7563979
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of KW-3902, an adenosine A1-receptor antagonist, in Dahl salt-sensitive rats.
Nomura H; Nagashima K; Kusaka H; Karasawa A
Jpn J Pharmacol; 1995 Aug; 68(4):389-96. PubMed ID: 8531413
[TBL] [Abstract][Full Text] [Related]
13. Effects of KW-3902, a selective and potent adenosine A1 receptor antagonist, on renal hemodynamics and urine formation in anesthetized dogs.
Aki Y; Tomohiro A; Nishiyama A; Kiyomoto K; Kimura S; Abe Y
Pharmacology; 1997 Oct; 55(4):193-201. PubMed ID: 9396079
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine A1-agonist and -antagonist on urinary volume and Na excretion in IAP-treated and non-treated rats.
Mizumoto H; Karasawa A
Jpn J Pharmacol; 1993 Oct; 63(2):257-9. PubMed ID: 8283837
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular site of action of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized rats.
Mizumoto H; Karasawa A
Jpn J Pharmacol; 1993 Mar; 61(3):251-3. PubMed ID: 8483302
[TBL] [Abstract][Full Text] [Related]
16. [Effect of KW-3902, a selective adenosine A1-receptor antagonist, on accumulation of gentamicin in the proximal renal tubules in rats].
Yao K
Yakugaku Zasshi; 2000 Sep; 120(9):801-5. PubMed ID: 11019653
[TBL] [Abstract][Full Text] [Related]
17. Increased diuretic response to furosemide in rats with glycerol-induced acute renal failure.
Kamiya A; Hayashi Y; Kikkoji T; Huang Y; Inui K; Hori R
J Pharmacobiodyn; 1988 Aug; 11(8):541-8. PubMed ID: 3236211
[TBL] [Abstract][Full Text] [Related]
18. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
[TBL] [Abstract][Full Text] [Related]
19. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
[TBL] [Abstract][Full Text] [Related]
20. The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency.
Yao K; Heyne N; Erley CM; Risler T; Osswald H
Eur J Pharmacol; 2001 Feb; 414(1):99-104. PubMed ID: 11231000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
